Geoff Martha, CEO of Medtronic, faced challenges in 2015 with an underperforming division but opted for long-term investment in neuromodulation technology. This strategy is now proving successful, exemplified by the recent approval of their adaptive deep brain simulation (aDBS) for Parkinson's disease. Medtronic's legacy of innovation and commitment to patient welfare, epitomized by a mission statement from its founder, underscores the importance of perseverance and strategic long-term planning in the medical technology sector.
Despite facing tough decisions in a challenging industry, Medtronic's leadership committed to long-term technology investments, demonstrating the power of perseverance in innovation.
Our leadership team joined hands, we said, 'this is what we're going to do, and it's going to be a long-term play.'
Collection
[
|
...
]